Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Behavioral effects of the novel cannabinoid full agonist AM 411.
McLaughlin PJ, Lu D, Winston KM, Thakur G, Swezey LA, Makriyannis A, Salamone JD. McLaughlin PJ, et al. Among authors: makriyannis a. Pharmacol Biochem Behav. 2005 May;81(1):78-88. doi: 10.1016/j.pbb.2005.02.005. Epub 2005 Apr 21. Pharmacol Biochem Behav. 2005. PMID: 15894067
Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.
McLaughlin PJ, Qian L, Wood JT, Wisniecki A, Winston KM, Swezey LA, Ishiwari K, Betz AJ, Pandarinathan L, Xu W, Makriyannis A, Salamone JD. McLaughlin PJ, et al. Among authors: makriyannis a. Pharmacol Biochem Behav. 2006 Mar;83(3):396-402. doi: 10.1016/j.pbb.2006.02.022. Epub 2006 Mar 6. Pharmacol Biochem Behav. 2006. PMID: 16616951
Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.
McLaughlin PJ, Thakur GA, Vemuri VK, McClure ED, Brown CM, Winston KM, Wood JT, Makriyannis A, Salamone JD. McLaughlin PJ, et al. Among authors: makriyannis a. Pharmacol Biochem Behav. 2013 Aug;109:16-22. doi: 10.1016/j.pbb.2013.04.011. Epub 2013 Apr 19. Pharmacol Biochem Behav. 2013. PMID: 23603029 Free PMC article.
Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
Järbe TU, LeMay BJ, Olszewska T, Vemuri VK, Wood JT, Makriyannis A. Järbe TU, et al. Among authors: makriyannis a. Pharmacol Biochem Behav. 2008 Nov;91(1):84-90. doi: 10.1016/j.pbb.2008.06.014. Epub 2008 Jun 29. Pharmacol Biochem Behav. 2008. PMID: 18640150 Free PMC article.
Unlike the CB1R antagonist rimonabant, in vitro (e.g., [Sink K.S., McLaughlin P.J., Wood J.A., Brown C., Fan P., Vemuri V.K., Pang Y., Olzewska T., Thakur G.A., Makriyannis A., Parker L.A., Salamone J.D. ...A neutral CB1 receptor antagoni …
Unlike the CB1R antagonist rimonabant, in vitro (e.g., [Sink K.S., McLaughlin P.J., Wood J.A., Brown C., Fan P., Vemuri V.K., Pang Y. …
514 results